PEPD is a pivotal regulator of p53 tumor suppressor

被引:24
|
作者
Yang, Lu [1 ]
Li, Yun [1 ,2 ]
Bhattacharya, Arup [1 ]
Zhang, Yuesheng [1 ,3 ]
机构
[1] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA
来源
NATURE COMMUNICATIONS | 2017年 / 8卷
关键词
PROTEIN-PROTEIN INTERACTION; GROWTH-FACTOR RECEPTOR; PROLINE-RICH DOMAIN; PROLIDASE DEFICIENCY; SH3; DOMAIN; EXPRESSION; APOPTOSIS; ENZYME; TRANSACTIVATION; CHEMOTHERAPY;
D O I
10.1038/s41467-017-02097-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
p53 tumor suppressor responds to various cellular stresses and regulates cell fate. Here, we show that peptidase D (PEPD) binds and suppresses over half of nuclear and cytoplasmic p53 under normal conditions, independent of its enzymatic activity. Eliminating PEPD causes cell death and tumor regression due to p53 activation. PEPD binds to the proline-rich domain in p53, which inhibits phosphorylation of nuclear p53 and MDM2-mediated mitochondrial translocation of nuclear and cytoplasmic p53. However, the PEPD-p53 complex is critical for p53 response to stress, as stress signals doxorubicin and H2O2 each must free p53 from PEPD in order to achieve robust p53 activation, which is mediated by reactive oxygen species. Thus, PEPD stores p53 for the stress response, but this also renders cells dependent on PEPD for survival, as it suppresses p53. This finding provides further understanding of p53 regulation and may have significant implications for the treatment of cancer and other diseases.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] P53 - HOW A TUMOR SUPPRESSOR WORKS
    BLUME, E
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (03) : 158 - 160
  • [32] P53 - A TUMOR-SUPPRESSOR GENE
    WUSTROW, TPU
    HNO, 1993, 41 (05) : A12 - A13
  • [33] The antioxidant function of the p53 tumor suppressor
    Anna A Sablina
    Andrei V Budanov
    Galina V Ilyinskaya
    Larissa S Agapova
    Julia E Kravchenko
    Peter M Chumakov
    Nature Medicine, 2005, 11 : 1306 - 1313
  • [34] P53 - THE ULTIMATE TUMOR SUPPRESSOR GENE
    OREN, M
    FASEB JOURNAL, 1992, 6 (13): : 3169 - 3176
  • [35] Structural biology of the tumor suppressor p53
    Joerger, Andreas C.
    Fersht, Alan R.
    ANNUAL REVIEW OF BIOCHEMISTRY, 2008, 77 : 557 - 582
  • [36] Microbial Regulation of p53 Tumor Suppressor
    Zaika, Alexander I.
    Wei, Jinxiong
    Noto, Jennifer M.
    Peek, Richard M.
    PLOS PATHOGENS, 2015, 11 (09)
  • [37] THE P53 TUMOR-SUPPRESSOR GENE
    LEVINE, AJ
    CHANG, AW
    DITTMER, D
    NOTTERMAN, DA
    SILVER, A
    THORN, K
    WELSH, D
    WU, M
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 123 (06): : 817 - 823
  • [38] Role of the p53 tumor suppressor in metabolism
    Lacroix, Matthieu
    Linares, Laetitia Karine
    Le Cam, Laurent
    M S-MEDECINE SCIENCES, 2013, 29 (12): : 1125 - 1130
  • [39] The two faces of tumor suppressor p53
    Smith, ML
    Fornace, AJ
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (04): : 1019 - 1022
  • [40] Tumor suppressor crosstalk: Hippo and p53
    Furth, N.
    Bossel, N.
    Pozniak, Y.
    Geiger, T.
    Domany, E.
    Aylon, Y.
    Oren, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S50 - S50